58 results
Pathophysiology of the Renin-angiotensin-aldosterone system (RAAS) and inhibitors

#Pathophysiology #Pharmacology #RAAS #Renin #Angiotensin #Aldosterone #System #ACEInhibitors
Pathophysiology ... system (RAAS) and ... inhibitors #Pathophysiology ... #Pharmacology #
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Xa Inhibitors - ... Oral Xa inhibitors ... overview of the dosing ... #Rivaroxaban #Dosing ... #Pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Dosing Increase ... #Renal #Dosing ... #Pharmacology #Management ... Diabetes #DM2 #Endocrinology
Stress Dose Steroids - Indications and Dosing

SUPPRESSED HPA AXIS:
 prednisone >20mg/day x 3 weeks or more
- Indications and ... Dosing SUPPRESSED ... #Indications #Dosing ... #Endocrinology ... Diagnosis #Management #Pharmacology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors ... PDE5 inhibitors  ... PDE5 inhibitors ... #pharmacology #comparison ... #medications #dosing
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
vary in potency and ... pharmacokinetic and ... during hospitalization ... platelet inhibition and ... ticagrelor #prasugrel #pharmacology
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
in Cirrhosis • Pathophysiology ... gastropathy • Dosing ... and Targets: Propranolol ... hepatology #management #pharmacology ... #indications #dosing
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Topical Calcineurin Inhibitors ... therapy is non-pharmacologic ... the first line pharmacologic ... If patients using ... #Medications #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... inactivates GLP-1 and ... #Pharmacology # ... DM2 #diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Mechanisms of Action: Inhibits ... #Pharmacology # ... DM2 #diabetes #endocrinology